COMPOSITION
Enrocure 10% Injectable Solution is a sterile, particule-free, clear light yellow colored solution, containing 100 mg of enrofloxacin and 30 mg of n-butanol as a preservative per milliliter.
INDICATION FOR USE
Cattle
- Treatment of infections of the respiratory tract caused by enrofloxacin
susceptible strains of
Pasteurella multocida, Mannheimia haemolytica and
Mycoplasma spp.
- Treatment of acute severe mastitis caused by enrofloxacin susceptible strains
of
Escherichia coli.
- Treatment of infections of the alimentary tract caused by enrofloxacin
susceptible strains of
Escherichia coli.
- Treatment of septicaemia caused by enrofloxacin susceptible strains of
Escherichia coli.
- Treatment of acute mycoplasma-associated arthritis due to enrofloxacin
susceptible strains of
Mycoplasma bovis in cattle less than 2 years old.
Sheep
- Treatment of infections of the alimentary tract caused by enrofloxacin
susceptible strains of
Escherichia coli.
- Treatment of septicaemia caused by enrofloxacin susceptible strains of
Escherichia coli.
- Treatment of mastitis caused by enrofloxacin susceptible strains of
Staphylococcus aureus and
Escherichia coli.
Goat
- Treatment of infections of the respiratory tract caused by enrofloxacin
susceptible strains of
Pasteurella multocida and
Mannheimia haemolytica.
- Treatment of infections of the alimentary tract caused by enrofloxacin
susceptible strains of
Escherichia coli.
- Treatment of septicaemia caused by enrofloxacin susceptible strains of
Escherichia coli.
- Treatment of mastitis caused by enrofloxacin susceptible strains of
Staphylococcus aureus and
Escherichia coli.
ADMINISTRATION ROUTES AND AMOUNTS
Repeated injections should be made at different injection sites.
To ensure correct dosage, body weight should be determined as accurately as possible to avoid underdosing.
Cattle
It is administered at dose of 5 mg of enrofloxacin/kg bw, (corresponding to 1 ml/20 kg bw), once daily for 3-5 days.
It is administered for 5 days in cattle under 2 years of age with acute arthritis of Mycoplasma origin.
It is administered by slow intravenous or subcutaneous administration.
At dose of 5 mg enrofloxacin/kg bw (corresponding to 1 ml/20 kg bw) is administered by slow intravenous injection once daily for two consecutive days in Acute mastitis caused by
Escherichia coli. The second dose may be administered by the subcutaneous route. In this case, the withdrawal period following subcutaneous injection applies. Not more than 10 ml should be administered at one injection site
Sheep-Goat
It is administered at dose of 5 mg of enrofloxacin/kg bw (corresponding to 1 ml/20 kg bw), once daily by subcutaneous injection for 3 days.
Not more than 6 ml should be administered at one injection site.
WITHDRAWAL PERIOD(S)
During the treatment and after the last drug administration cattle should not be sent for slaughter for 5 days following intravenous application, for 12 days following subcutaneous application. Sheep and goats should not be slaughtered during the treatment and for 4 and 6 days, respectively following the last drug administration. During the treatment and after the last drug administration cow milk should not be used for human consumption for 3 days after intravenous application, and 4 days after subcutaneous application. Sheep and goat milk should not be used for human consumption during the treatment and for 3 days and 4 days respectively after the last drug administration.
MARKETING PACKAGING
Sold as 20, 50, 100 ml and 250 ml Type II amber-colored glass vials, sealed with bromobutyl rubber stopper and aluminum flip-off cap inside cardboard boxes.
